iiinova — where your digital self keeps evolving

Reposted by Joe W. Ramos, PhD

The Lundquist Institute @thelundquist.bsky.social · 07/01/2026

TLI is proud to welcome Michelle L. Matter, PhD, whose expertise in #cardiomyopathies, sepsis, and cellular signaling will strengthen our research in #cardiovascular medicine. Join us in celebrating her arrival and the exciting scientific impact ahead!🔬Learn about Dr. Matter's work: bit.ly/4jp8b6c

032

Reposted by Joe W. Ramos, PhD

The Lundquist Institute @thelundquist.bsky.social · 12/01/2026

TLI investigator Michelle Matter, PhD, and her team identify a new molecular mechanism that helps the heart adapt to #pregnancy. Published in Nature Communications, the study highlights the role of the PTRH2 gene and potential paths to targeted therapies. Read more: bit.ly/3L7VpfZ #WomensHealth

011

Reposted by Joe W. Ramos, PhD

The Lundquist Institute @thelundquist.bsky.social · 13/01/2026

Join us on January 21 at 1pm PT as TLI Investigator Lynda Polgreen, MD, MS, recipient of the Richard E. Weitzman Investigator Award, traces the 25-year journey from the discovery of Aldurazyme, the first enzyme replacement therapy for MPS, to today’s expanding therapeutic landscape: bit.ly/4aXtmub

011

Reposted by Joe W. Ramos, PhD

The Lundquist Institute @thelundquist.bsky.social · 14/01/2026

Applications are now open for 2026 The Lundquist Institute High School Summer Fellows Program! 🔬🧬🧪 The program is open to junior and senior high school students. More info: lundquist.org/high-school-summer-fellows/ #education #STEM #bioscience #educationresearch #scienceprogram #summerprogram

011

Joe W. Ramos, PhD @joewramos.bsky.social · 07/12/2025

I am happy to share our latest paper in JBC. This work is focused on better understanding cancer invasion programs - especially in brain cancer. We are mapping key proteins in cancer invasion programs that allow cancer cells to move to other parts of the body. www.jbc.org/article/S002...

jbc.org

Phosphorylation at S1288 of Leukemia Associated RhoGEF (LARG/ARHGEF12) induces plasma membrane localization and promotes binding and activation of RhoA

Leukemia-associated RhoGEF (LARG) is a guanine nucleotide exchange factor (GEF) known for its specificity towards Ras homolog family member A (RhoA). LARG plays a crucial regulatory role in various ce...

010

Reposted by Joe W. Ramos, PhD

The Lundquist Institute @thelundquist.bsky.social · 08/09/2025

We're here at the Association of Independent Research Institutes' #AIRI2025 #conference in Washington, D.C.—immersed in powerful conversations with fellow research leaders and peer institutions to advocate for the future of #science and #research! 🧬🔬

011

Reposted by Joe W. Ramos, PhD

The Lundquist Institute @thelundquist.bsky.social · 15/09/2025

This week marks #FungalWeek25 to highlight the growing #publichealth threat posed by fungal infections. 🦠 Our recent stories show our commitment to advancing translational research and the impact of our science. Read more about our work and other critical research at TLI: bit.ly/3VOw24g

011

Reposted by Joe W. Ramos, PhD

The Lundquist Institute @thelundquist.bsky.social · 29/08/2025

TLI's Frans Walther and his team have created a low‑cost, aerosolizing lung surfactant therapy that could revolutionize #treatment for premature #infants worldwide. Even @billgates.bsky.social called this medical advancement “kind of a miracle.” Read more: bit.ly/3JSXTNY

bit.ly

Breath of Life: LA Scientist’s Innovation Earns Global Applause, Including from Bill Gates

Frans Walther, MD, PhD, a physician-scientist at The Lundquist Institute, and his research group have developed a low-cost, aerosolized synthetic lung surfactant therapy to treat infant respiratory di...

001

Reposted by Joe W. Ramos, PhD

The Lundquist Institute @thelundquist.bsky.social · 29/08/2025

From exploring the link between sleep loss and diabetes to unlocking pneumonia immunity, our latest newsletter highlights pioneering #research news, event highlights, and more insights on what's happening at TLI🔬 Keep up with TLI by subscribing to our newsletter, On The Edge: bit.ly/4g1iY4Y

011

Reposted by Joe W. Ramos, PhD

The Lundquist Institute @thelundquist.bsky.social · 20/08/2025

At TLI, we’re breaking down barriers and building bridges to better access and support. This year's UCLA CTSI CERP Symposium brought together leaders, researchers, and #community partners to explore new ways of connecting communities to #mentalhealth care. Read more about the event: bit.ly/3UElS5T

bit.ly

Connecting Communities to Mental Health Care: A Look Back at the 2025 UCLA CTSI CERP Symposium

The Community Engagement and Research Program (CERP) identifies and researches public health priorities to improve healthcare access in Los Angeles County.

001

Reposted by Joe W. Ramos, PhD

The Lundquist Institute @thelundquist.bsky.social · 21/08/2025

We're honored to welcome US Senator Bill Cassidy, M.D., Chairman of the Senate Committee on Health, Education, Labor, and Pensions (HELP). During his time on campus, we shared some of our groundbreaking infectious disease research and efforts to combat drug-resistant threats: bit.ly/4mkw1Rn.

032

Reposted by Joe W. Ramos, PhD

The Lundquist Institute @thelundquist.bsky.social · 22/08/2025

Meet Melanie and Richard Lundquist, whose deep-rooted passion in advancing life‑saving biomedical research and visionary support have powered transformational change at TLI. Read more about their legacy and heartfelt connection to our mission: bit.ly/3UHbyKs #philanthropy #donorimpact #giving

022

Reposted by Joe W. Ramos, PhD

The Lundquist Institute @thelundquist.bsky.social · 13/08/2025

Our new and improved website is live! 🎉 Built with fresh visuals, streamlined navigation, and a more accessible design—the new Lundquist.org makes it easier than ever to explore our mission, impact, and the groundbreaking work happening every day at TLI. Check it out! lundquist.org

022

Reposted by Joe W. Ramos, PhD

The Lundquist Institute @thelundquist.bsky.social · 20/03/2025

Mucormycosis is a fungal infection that causes severe disease and fatality, especially in immunocompromised individuals. 🔬🧪 Learn more about the antibody Investigator Dr. Ashraf Ibrahim, Dr. Yiyou Gu, and their team has developed that could be a promising treatment: bit.ly/4iHC8x0 #Immunotherapy

022

Reposted by Joe W. Ramos, PhD

The Lundquist Institute @thelundquist.bsky.social · 27/03/2025

#DidYouKnow Reaching 150 minutes of moderate-to-vigorous physical activity, plus muscle training twice a week, can improve health and increase longevity. Here’s a recap of our previous Science and Your Health with TLI Investigator @harrybrossiter.bsky.social. #exercise #workout #wellbeing #health

021

Reposted by Joe W. Ramos, PhD

The Lundquist Institute @thelundquist.bsky.social · 28/03/2025

In 1978, the Institute launched its High School Summer Fellows Program for rising high school juniors and seniors to explore careers in biomedical science. Among the first cohort was Christian de Virgilio, MD who credits the program for his acceptance to the @dgsomucla.bsky.social: bit.ly/42esKKD

021

Reposted by Joe W. Ramos, PhD

The Lundquist Institute @thelundquist.bsky.social · 28/02/2025

Our Center for Treatment of #RareDisease, led by TLI Investigator Lynda Polgreen, MD, MS, is committed to advancing patient care by developing life-changing treatments. #RareDiseaseDay. Thanks to the Susan Scott Foundation's continued support, we're able to accelerate our #research and impact.

022